Ipilimumab vs Metformin

## Ipilimumab vs Metformin: Overview

This comparison examines the pharmacological differences between **Ipilimumab** and **Metformin**.

## Mechanism of Action

**Ipilimumab**: Fully human anti-CTLA-4 IgG1 monoclonal antibody that blocks CTLA-4 inhibitory signaling.

**Metformin**: Activates AMP-activated protein kinase, decreasing hepatic glucose production.

## Pharmacokinetics

**Half-life**: Ipilimumab — 14.7 days; Metformin — 4-9 hours.

## Chemical Properties

**Molecular Formula**: Ipilimumab — N/A; Metformin — C4H11N5.

**Molecular Weight**: Ipilimumab — N/A; Metformin — 129.1640 g/mol.

**Type**: Ipilimumab — Antibody; Metformin — Small molecule.